Star Metro - Bausch Health to Announce Third Quarter 2025 Results on October 29

NYSE - LSE

SCS	0%	15.76	$
RIO	0.09%	69.33	$
CMSC	0.29%	23.85	$
BCE	0.09%	23.19	$
CMSD	0.37%	24.1	$
BTI	0.7%	54.59	$
JRI	-0.07%	13.74	$
NGG	1.88%	77.75	$
BCC	-0.13%	70.64	$
BP	2.08%	36.58	$
GSK	-1.01%	46.63	$
AZN	0.96%	84.58	$
RBGPF	-1.04%	75.22	$
VOD	2.07%	11.58	$
RELX	-2.65%	42.27	$
RYCEF	0.54%	14.88	$

Bausch Health to Announce Third Quarter 2025 Results on October 29

BOULEVARD 30.09.2025

Bausch Health to Announce Third Quarter 2025 Results on October 29

LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Text size:

Conference Call Details

Date:	Wednesday, October 29, 2025
Time:	5:00 p.m. U.S. EDT
Webcast:	http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

###